Skip to main content

Advertisement

Log in

Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma

  • Letter to the Editor
  • Published:
Hepatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

All original data can be obtained upon reasonable request directed to the first author.

References

  1. Choi HSJ, Brouwer WP, Zanjir WMR, et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71(2):539–548

    Article  CAS  PubMed  Google Scholar 

  2. Huang SC, Su TH, Tseng TC, et al. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B. Hepatol Int. 2023;17(5):1139–1149

    Article  PubMed  Google Scholar 

  3. Mao X, Cheung KS, Peng C, et al. Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta-analysis. Hepatology. 2023;77(5):1735–1745

    Article  PubMed  Google Scholar 

  4. van Meer S, van Erpecum KJ, Sprengers D, et al. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands. Eur J Gastroenterol Hepatol. 2016;28(3):352–359

    Article  PubMed  Google Scholar 

  5. Wong YJ, Nguyen VH, Yang HI, et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023;29(3):705–720

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mak LY, Hui RW, Fung J, et al. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. J Hepatol. 2020;73(4):800–806

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Robert J. de Knegt consults and received grants from AbbVie. He is on the speakers’ bureau for Echosens. He received grants from Gilead and Janssen. We confirm that the parties mentioned above have been involved in this manuscript or have funded this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ibrahim Ayada.

Ethics declarations

Conflict of interest

The authors have not disclosed any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 38 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ayada, I., Li, J., Brouwer, W.P. et al. Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma. Hepatol Int 18, 1053–1055 (2024). https://doi.org/10.1007/s12072-024-10639-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-024-10639-9

Navigation